ArticleInternal medicine (Tokyo, Japan)2021

Successful Treatment with Afatinib after Osimertinib-induced Interstitial Lung Disease in a Patient with EGFR-mutant Non-small-cell Lung Cancer.

Shunichi Nishima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.